title: Evaluation of a porous, biodegradable biopolymer scaffold for mandibular reconstruction.
abstract: OBJECTIVE
  Bioresorbable bone graft substitutes could eliminate disadvantages associated with the use of autografts, allografts, and other synthetic materials. The authors investigated the osteoinductive capacity of a bioresorbable bone graft substitute made from the unsaturated polyester poly(propylene glycol-co-fumaric acid) (PPF) for mandibular reconstruction in a rat model. The eventual intention is to use this material either as a stand-alone bone graft substitute or as an extender to autograft harvested from mandibular reconstruction sites.
  
  
  METHODS
  The PPF bone graft was crosslinked in the presence of a hydroxyapatite filler and effervescent foaming agents to develop porosity in situ by generating carbon dioxide during the effervescent reaction of citric acid and sodium bicarbonate. The latter reagents are responsible for foam formation and expansion, resulting in a polymeric scaffold with pore sizes in the range of 100 to 500 microm. Twenty adult Sprague-Dawley rats had 3-mm-diameter cortical defects decorticated on the outer aspect of their left mandibular ramus using a Hall drill. Animals were divided into 2 groups of 10 animals each. Animals in group A were treated with implantation of the PPF-based bone graft substitute. Implants were applied buccally to defects on the left side. In group B animals with similar defects, the drill holes were left to heal unaided. The amount of new bone formation and the presence of an inflammatory infiltrate were evaluated at 7 weeks postoperatively.
  
  
  RESULTS
  Histologic analysis of the healing process revealed enhanced in vivo new bone formation with the PPF bone graft substitute. These findings were corroborated by the histomorphometric analysis of new bone formation.
  
  
  CONCLUSIONS
  Results of this study demonstrated biocompatibility of the porous PPF-based scaffold in a mandibular defect.
  
  
  CONCLUSIONS
  These findings may have applicability to the further development of bone graft substitutes for oral/maxillofacial applications.
authors.affiliation: Cambridge Scientific, Cambridge, Massachusetts 02138-1112, USA.
authors.forename: Debra J
authors.initials: DJ
authors.lastname: Trantolo
authors.forename: Stephen T
authors.initials: ST
authors.lastname: Sonis
authors.forename: Benjamin M J
authors.initials: BM
authors.lastname: Thompson
authors.forename: Donald L
authors.initials: DL
authors.lastname: Wise
authors.forename: Kai-Uwe
authors.initials: KU
authors.lastname: Lewandrowski
authors.forename: David D
authors.initials: DD
authors.lastname: Hile
mesh_terms: D020341:Absorbable Implants; D000704:Analysis of Variance; D000818:Animals; D001861:Bone Regeneration; D018786:Bone Substitutes; D008297:Male; D008334:Mandible / Q000601:surgery*; D011108:Polymers; D016062:Porosity; D011409:Propylene Glycols; D051381:Rats; D017207:Rats, Sprague-Dawley
chemical_list: D018786:Bone Substitutes; D011108:Polymers; D011409:Propylene Glycols; C106431:poly(propylene glycol-fumarate)